Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are breastfeeding, Specialist Pharmacy Service (published 12th October 2021)

Breastfeeding of full-term and healthy infants can continue if treatment with tocilizumab and sarilumab are required. If the infant was born prematurely, is unwell, or the mother is taking multiple medicines, the UK Drugs in Lactation Advisory Service should be contacted.

Source: Current Awareness Service for Health (CASH) - October 13, 2021 Category: Consumer Health News Source Type: news